Antibacterial activity of FK 749 against ampicillin-resistant clinical isolates of Escherichia coli was compared with those of other newly developed cephalosporins. FK 749 was the most active against strains possessing R-plasmids specifying ampicillin resistance and those whose resistance was chromosomally determined. The susceptibility of ampicillin-susceptible E. coli to FK 749 was not decreased by transduction of ampicillin resistance-specifying plasmids. However, most of the transconjugants acquired a high level of resistance to cefoperazone and cefamandole and a moderate level to cefotiam. FK 749 was highly stable to both penicillinase-and cephalosporinase-type ,8-lactamases, including R-plasmid-mediated f8-lactamase. Its level of resistance to ,B-lactamases was comparable to those of cefoxitin, cefmetazole, and cefotaxime, slightly superior to that of cefuroxime, and much superior to those of cefotiam, cefamandole, and cefoperazone.
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Cephalosporin antibiotics are superior to other families of antibiotics in their low toxicity and significant antibacterial activity against a large number of gram-positive and -negative bacteria. However, the following two recent situations are of great concern for the antibacterial activity of cephalosporins against gram-negative bacteria. The first is the gradual increase of noncephalosporin-susceptible gram-negative species among clinical isolates, such as Serratia, Enterobacter, Citrobacter, Proteus, and Pseudomonas (3) . The other is the elevation of the level of cephalosporin resistance mediated by plasmids specifying fl-lactamase, resulting in the increase of moderately cephalosporin-resistant strains in Enterobacteriaceae including Escherichia coli and Klebsiella pneumoniae (2, 5, 6) .
This report describes the antibacterial activity of FK 749, a cephalosporin derivative newly developed in our research laboratories (4), against the above-mentioned cephalosporin-resistant bacteria, especially against R-plasmidpossessing strains. This report also describes the stability of FK 749 to /3-lactamases.
MATERIALS AND METHODS
Bacterial strains. E. coli CSH2 (naF), 17 (4) . Meanwhile, the other cephalosporin and cephamycin derivatives were 2 to 25 times less effective than FK 749 against R-plasmid-harboring strains and 5 to 100 times less effective against chromosomally resistant strains.
Influence of R-plasmids encoding ampicillin resistance on the antibacterial activity of FK 749. The net influence of R-plasmids encoding ampicillin resistance on the antibacterial activities of cephalosporin derivatives was assessed by comparing the activity of cephalosporins against E. coli CSH2 to that against strains of E. coli CSH2 possessing R-plasmids. Strains possessing R-plasmids were constructed by conjugal transfer of R-plasmids from clinical isolates of E. coli (8 strains) and of K. pneumoniae (9 strains) to E. coli CSH2. Figure 1 shows the MICs of cephalosporins against E. coli CSH2 and the distribution of the MICs against 17 strains of E. coli CSH2 harboring Apr R-plasmids. Of the nine cephalosporins tested (FK 749, cefotiam, cefamandole, cefuroxime, cefotaxime, cefmetazole, cefoxitin, cefoper- azone, and cefazolin), the antibacterial activity of cefoperazone was the most influenced by the R-plasmids, followed by that ofcefamandole and cefotiam. As shown in Fig. 1 , 65% of the plasmidharboring strains of E. coli CSH2 were resistant to 400 pg and above of cefoperazone and cefamandole per ml, whereas the MICs of cefoperazone and cefamandole against plasmid-free E. coli CSH2 were 1.56 and 3.13 pLg/ml, respectively. The MICs of cefotiam against the plasmid-possessing strains ranged widely from 1.56 to 100lg/ml, whereas cefotiam inhibited the plasmid-free strains at 1.56 pg/ml. Meanwhile, the effect of the R-plasmids on the antibacterial activities of cefuroxime, cefotaxime, and cephamycins (cefoxitin and cefmetazole) was notably less, although their activities were reduced twoto fourfold in the presence of the R-plasmids. In contrast, the MICs of FK 749 against strains possessing the Apr R-plasmids were shown to coincide with its MIC against the plasmid-free strain. This result clearly indicates that the antibacterial activity of FK 749 is not reduced by R-plasmids specifying ampicillin resistance.
Stability of FK 749 to f-lactamase. Stability of FK 749 to ,B-lactamase was compared with that of the nine ,B-lactam antibiotics cefotiam, cefamandole, cefuroxime, cefmetazole, cefoxitin, cefoperazone, cefazolin, cephaloridine, and penicillin G. According to the classification proposed by Richmond and Sykes (7), nine distinct types of f4-lactamases were selected from clinical isolates of gram-negative bacilli and used for assay, together with the enzyme from ampicillin-resistant S. aureus. Class I enzymes are cephalosporinases, whereas class IH, III, IV, and V, and S. aureus enzymes are termed penicillinases. The relative initial rates of hydrolysis of the cephalosporins were expressed in percentage of hy- drolysis of cephaloridine for cephalosporinase and of penicillin G for penicillinase. FK 749 was extremely stable against all types of,-lactamases, as were the two cephamycin derivatives, cefmetazole and cefoxitin ( 'Relative initial velocity: cephaloridine = 100 for cephalosporinase, penicillin G = 100 for penicilhinase.
Ultraviolet assay, 37°C, 0.067 M potassium phosphate buffer (pH 7.0). Classes and sources of ,B-lactamase were: Ia (1), S. marcescens 78; Ia (2), E. cloacae 91; Ib, E. coli 35 (C+); Ic, P. vulgaris 9; Id, P. aeruginosa 11 (C+); II, P. mirabilis 133; III, E. coli 18 (R+); IV, K. pneumoniae 134; V, P. aeruginosa 47 (R+); S. aureus, S. aureus 35.
substrate profile, hydrolyzed this antibiotic rapidly.
FK 749 was extremely stable to class I enzymes from the non-cephalosporin-susceptible gram-negative species such as Enterobacter spp., Citrobacter freundii (not shown), S. marcescens, and P. aeruginosa, as well as chromosomally resistant E. coli. FK 749 showed excellent antibacterial activity against these organisms. Furthermore, the stability of FK 749 to R-plasmid-coded ,B-lactamase was shown to be excellent. This result explains the fact that the antibacterial activity of FK 749 was scarcely reduced in the presence of Apr R-plasmids. DISCUSSION R-plasmids specifying ampicillin resistance confer a high level of resistance to the penicillins on gram-negative bacterial species. However, there has been relatively little attention to this type of R-plasmids from the viewpoint of cephalosporin resistance, since only some of these plasmids could confer moderate levels of resistance to the cephalosporins. However, it is noteworthy that the frequency of isolation of strains possessing Apr R-plasmids conferring moderate levels of resistance to the cephalosporins has been increasing recently. The explanation for this phenomenon would seem to be that the level of production of plasmid-mediated ,B-lactamases has been elevated, together with the fact that the Apr R-plasmids have spread extensively among the enteric bacteria. A series of newly developed cephalosporins were tested for their antibacterial activities against Apr R-plasmid-containing strains in this study. The results show that the antibacterial activities of cefoperazone, cefamandole, and cefotiam were markedly reduced in the presence of Apr R-plasmids, to the same level as the existing cephalosporins such as cephaloridine. Notably, the antibacterial activities of cefoperazone and cefamandole were reduced more than that of cefazolin. Meanwhile, the antibacterial activities of the methoxyimino cephalosporin derivatives, as well as the cephamycin derivatives, were much less influenced by the Apr R-plasmids. Particularly, the antibacterial activity of FK 749 was found to be completely free from the plasmids. Among the above-mentioned antibiotics, FK 749 was the most active against Apr R-plasmid-containing strains of E. coli. The exceptional stability of FK 749 to R-plasmid-mediated ,B-lactamase is due to this property against the Apr R-plasmids. However, a discrepancy was observed with cefoxitin between its extreme stability to the plasmid-mediated enzyme and the slight decrease in its antibacterial activity against the plasmid-possessing strains. This might result from its comparatively poor ability to penetrate through the bacterial outer membrane (H. Kojo, Y. Shigi, and M. Nishida, unpublished data).
The cephamycin derivatives showed excellent stability to ,B-lactamases from non-cephalosporin-susceptible species such as Enterobacter spp., C. freundii, S. marcescens, and indole-positive Proteus spp., whose resistance to the cephalosporins was assumed to originate principally from their cephalosporinases. Against these species, however, the cephamycins were not as active as expected from their stability to the cephalosporinases. Meanwhile, FK 749 was similar to the cephamycins in its extreme stability to species-specific ,B-lactamases, but it was quite different from the cephamycins in that it showed a significant antibacterial activity against the non-cephalosporin-susceptible species (4 
